z-logo
open-access-imgOpen Access
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Author(s) -
Kin Man Au,
Steven Park,
Andrew Z. Wang
Publication year - 2020
Publication title -
science advances
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aba8564
Subject(s) - chemoimmunotherapy , cancer research , cytotoxic t cell , natural killer cell , immunotherapy , cd16 , immunology , immune system , biology , cd8 , cd3 , biochemistry , in vitro
A trispecific natural killer cell engager platform has been successfully engineered for EGFR-targeted chemoimmunotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom